The anti-tumor effect of curcumin analogue CDF in gemcitabine-resistant pancreatic cancer cells was mainly achieved by down-regulating miR-21 and thus up-regulating PTEN expression [25]. This evidence concerns the gene PTEN and pancreatic neoplasm.